Affymetrix Inc. and Baylor College of Medicine have entered into an agreement in which Baylor receives a non-exclusive, worldwide license to use Affymetrix's comparative genomic hybridization (CGH) microarrays. Baylor intends to use the microarrays in services provided in Clinical Laboratory Improvement Amendments (CLIA) environments. The Press Release providing this news can be found here.
Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.
http://health86.narod.com/index.html
Posted by: SAMUEL | April 03, 2007 at 06:13 PM